Endothelial dysfunction and inflammation induced by iron oxide nanoparticle exposure: Risk factors for early atherosclerosis. - Wikidata - awgldk - TriplyDB

Endothelial dysfunction and inflammation induced by iron oxide nanoparticle exposure: Risk factors for early atherosclerosis.

Endothelial dysfunction and inflammation induced by iron oxide nanoparticle exposure: Risk factors for early atherosclerosis.

http://www.wikidata.org/entity/Q42744617

about

Tight junction between endothelial cells: the interaction between nanoparticles and blood vessels Safety of Nanoparticles in Medicine Nanotoxicity overview: nano-threat to susceptible populations Interaction of graphene nanoribbons with components of the blood vascular system Silica nanoparticles induce oxidative stress, inflammation, and endothelial dysfunction in vitro via activation of the MAPK/Nrf2 pathway and nuclear factor-κB signaling Physicochemical properties determine nanomaterial cellular uptake, transport, and fate Oxidative DNA damage from nanoparticle exposure and its application to workers' health: a literature review Effects of the physicochemical properties of titanium dioxide nanoparticles, commonly used as sun protection agents, on microvascular endothelial cells Effect of nanoparticles exposure on fractional exhaled nitric oxide (FENO) in workers exposed to nanomaterials Xenobiotic particle exposure and microvascular endpoints: a call to arms Thrombospondin-1 mediates multi-walled carbon nanotube induced impairment of arteriolar dilation Strategies to overcome the barrier: use of nanoparticles as carriers and modulators of barrier properties.Age modulates Fe3O4 nanoparticles liver toxicity: dose-dependent decrease in mitochondrial respiratory chain complexes activities and coupling in middle-aged as compared to young rats.Effect of nanoparticles binding β-amyloid peptide on nitric oxide production by cultured endothelial cells and macrophages.The in-vivo use of superparamagnetic iron oxide nanoparticles to detect inflammation elicits a cytokine response but does not aggravate experimental arthritis.Enhancement of proinflammatory and procoagulant responses to silica particles by monocyte-endothelial cell interactions.Nanomedicine: tiny particles and machines give huge gains Engineering imaging probes and molecular machines for nanomedicine.Temporal techniques: dynamic tracking of nanomaterials in live cells.Understanding the particokinetics of engineered nanomaterials for safe and effective therapeutic applications.Nanoparticles and the cardiovascular system: a critical review.New paradigms in inflammatory signaling in vascular endothelial cells.Effects of metal(loid)-based nanomaterials on essential element homeostasis: the central role of nanometallomics for nanotoxicology.How physico-chemical characteristics of nanoparticles cause their toxicity: complex and unresolved interrelations.Perturbation of physiological systems by nanoparticles.Effects of iron oxide nanoparticles: cytotoxicity, genotoxicity, developmental toxicity, and neurotoxicity.Nanodiagnostics, nanopharmacology and nanotoxicology of platelet-vessel wall interactions.The biological effects upon the cardiovascular system consequent to exposure to particulates of less than 500 nm in size.The responses of immune cells to iron oxide nanoparticles.Detection and treatment of atherosclerosis using nanoparticles.Biodistribution of polyacrylic acid-coated iron oxide nanoparticles is associated with proinflammatory activation and liver toxicity.NOX4- and Nrf2-mediated oxidative stress induced by silver nanoparticles in vascular endothelial cells.Improved and targeted delivery of bioactive molecules to cells with magnetic layer-by-layer assembled microcapsules.Iron oxide nanoparticles can cross plasma membranes.Exposure characteristics of ferric oxide nanoparticles released during activities for manufacturing ferric oxide nanomaterials.Toxicity of Nanoparticles on the Reproductive System in Animal Models: A Review.Cardiovascular toxicity of different sizes amorphous silica nanoparticles in rats after intratracheal instillation.ZnS nanoarchitectures induced dysfunction of vascular endothelial cells in vitro and in vivo.Activation of the molecular and functional effects of Nrf2 against chronic iron oxide nanorod overload-induced cardiotoxicity.Iron oxide nanoparticles induced cytotoxicity, oxidative stress and DNA damage in lymphocytes.

P2860

Q26747571-8427525D-2CA6-4C6D-B7A3-32166FEE3080 Q28083076-B81B034B-F614-4007-9CB7-13AA81A3BDB7 Q28383369-7E2D9F0F-CA26-4628-9E01-8E31216065A8 Q28387840-11E988C2-21AE-468D-BD1E-3B31BDF1CDEA Q28388936-6B19325E-ADA5-4E6A-BBCA-FF49DE58ED0C Q28392819-67DF829F-24D5-46F3-BC5D-49C2D0E1C702 Q28394123-FB292523-7CCB-41F6-983F-6C935C2EDFB2 Q28394221-3ACB0BE8-6359-4B0F-AF6F-AEBCD9EFB88A Q28395218-E8C37101-7C5C-447A-BF83-A3EFEF5FECA1 Q28395533-5FEDFF8D-7AB5-4AC7-A698-B2C6EC9E8172 Q28917103-B0806033-D4F1-43F8-B648-64CD9E632352 Q30768284-E9D905DC-7F5C-4421-A8BD-A8F001602C88 Q33657071-ECD7DC2E-B8DE-41B3-87FF-992B630AEB88 Q34743677-5B2CE109-1E6F-4038-B6F7-D5868384588D Q35587047-1E3C99EA-1652-479C-AD11-A8BEA7575D34 Q36412377-BC218CD3-8175-4646-9217-4BB467FE8552 Q37656497-B7EE0A24-FF4E-4399-BD01-1B687DF5C6D8 Q38056410-E661D82A-07AB-4F10-8D7C-4A74E8F3F4DC Q38058456-247B80B5-0C72-4C4C-A5BA-BC48A8C45F17 Q38066154-9B43E7F8-7920-476E-9B75-5F5851E54DA9 Q38087984-E347C2B8-F8C3-47C1-99E7-4E86DFB97359 Q38166953-0B9AB685-2A6B-4276-A1D1-743B8B88A011 Q38191756-89324510-C7AF-4DB5-8E4A-5A7C91E5F294 Q38193109-E1FC8EEA-D724-46EB-9C85-E12851BE5097 Q38197488-41DEF38B-1251-4842-AC1E-C0184C83EE0A Q38248242-961AFC0D-4757-47AD-A3D0-F5EE990F73FE Q38495085-35148A13-8D67-436A-838C-2F5E413A3A84 Q38661601-AB371EAD-17A7-4008-80C2-ED58A3599E5C Q38799107-910B5869-65AF-4A79-BE32-92C4915C7153 Q38848673-98F3813F-C145-458E-A6D1-FEEA09D0440F Q39832600-EFA3A68B-D42B-4F47-AC34-93304B9DAE7A Q40496575-118A9860-38A1-40BD-8EB2-F13B1EB44B0E Q40954560-40E684C6-5731-46C3-A307-B5B37E89B16F Q41197251-238F2308-A434-401F-A1E4-072357636EC5 Q41373604-B2DD5587-BF6F-45DD-8B14-7BBC6091B6AB Q41453466-FF5CA61F-F03F-41EE-8FFF-EA64715E19C1 Q43615711-024FA9D8-D69C-4941-BB48-19E36A459203 Q45018868-DBEB7D3C-7FA9-4976-B7D5-531FA55A3DC1 Q46254751-1E5FAF47-9735-4A41-A4F0-BE0AB2BA75F6 Q46355542-9829ED1A-8FDF-4F7F-8F75-873E9FC17572

P2860

Endothelial dysfunction and inflammation induced by iron oxide nanoparticle exposure: Risk factors for early atherosclerosis.

http://www.wikidata.org/entity/Q42744617

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Endothelial dysfunction and in ...... ors for early atherosclerosis.

@en

Endothelial dysfunction and in ...... ors for early atherosclerosis.

@nl

type

label

Endothelial dysfunction and in ...... ors for early atherosclerosis.

@en

Endothelial dysfunction and in ...... ors for early atherosclerosis.

@nl

prefLabel

Endothelial dysfunction and in ...... ors for early atherosclerosis.

@en

Endothelial dysfunction and in ...... ors for early atherosclerosis.

@nl

P1433

Q42744617-24468188-A977-47A9-B225-CF7D1213EB73

P1476

Q42744617-65FDD167-F418-4273-882F-1F39EB20BF56

P2093

Q42744617-1C7846BB-3BD3-4C6E-8A37-CEB6E63A556B

Q42744617-3C233499-2DB7-4127-AB5D-C378618E03D8

Q42744617-3C27D780-1FC6-426F-9D33-44CC7678FC05

Q42744617-670725A0-536A-482F-8374-4CAB23A12043

Q42744617-710A7817-5375-4651-A628-22928E535E85

Q42744617-A52B72C7-3B52-4503-9F83-B89EF3A556D2

Q42744617-A7E3FC7A-563B-48DB-8358-29A7E1FD9BE5

Q42744617-F0046E8A-2932-4655-8FA9-A2BAD4A92613

Q42744617-FFDC93BC-53B9-4286-9CED-F251994267B7

P304

Q42744617-A23AD03C-97BB-4C96-BD09-DF76D34A012F

P31

Q42744617-981CD1AC-D8DB-4D5E-AD14-15145F0B427C

P356

Q42744617-3BBF2111-19F7-45BF-8798-744DD769DCAF

P433

Q42744617-309A7193-2601-44DB-B59F-60004E2C13BA

P478

Q42744617-F195CC2D-23A8-402D-B454-113CFC0A01DB

P50

Q42744617-08B65AAC-D4C7-4A88-B677-19B8B160A56E

P577

Q42744617-6956C132-99FA-484D-BB50-7EDBD0F8342E

P5875

Q42744617-6A697956-65AD-4A7F-9E7D-C67052BD3796

P698

Q42744617-AD532B38-1E59-4B4E-ADC1-52AD8D40A53C

P921

Q42744617-21016E9D-1891-4266-92BC-6E27A742B60C

Q42744617-B6AE27FA-500C-4448-8BA2-82C3B082E9B3

Q42744617-E8EFE036-10ED-4F18-B933-D35CD84A78D5

P356

J.TOXLET.2011.03.021

P1433

Toxicology Letters

P1476

Endothelial dysfunction and in ...... ors for early atherosclerosis.

@en

P2093

Bing Wang

http://www.w3.org/2001/XMLSchema#string

Hong Ouyang

http://www.w3.org/2001/XMLSchema#string

Hua-Jian Wang

http://www.w3.org/2001/XMLSchema#string

Lan Yuan

http://www.w3.org/2001/XMLSchema#string

Mo-Tao Zhu

http://www.w3.org/2001/XMLSchema#string

Wei-Yue Feng

http://www.w3.org/2001/XMLSchema#string

Yu-Liang Zhao

http://www.w3.org/2001/XMLSchema#string

Yun Wang

http://www.w3.org/2001/XMLSchema#string

Zhi-Fang Chai

http://www.w3.org/2001/XMLSchema#string

P304

162-171

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.TOXLET.2011.03.021

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

203

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50865853

http://www.w3.org/2001/XMLSchema#string

P698

21439359

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis